Literature DB >> 28214749

Impairment in the mesohippocampal dopamine circuit following exposure to the brominated flame retardant, HBCDD.

Camille Pham-Lake1, Elizabeth B Aronoff1, Chad R Camp1, Aimee Vester1, Sam J Peters1, W Michael Caudle2.   

Abstract

Many chemicals have been used to increase the safety of consumer products by reducing their flammability and risk for ignition. Recent focus on brominated flame retardants, such as polybrominated diphenyl ethers (PBDEs) has shown them to contribute to neurobehavioral deficits in children, including learning and memory. As the manufacture and use of PBDEs have been reduced, replacement chemicals, such as hexabromocyclododecane (HBCDD) have been substituted. Our current study evaluated the neurotoxicity of HBCDD, concentrating on dopaminergic innervation to the hippocampus. Using an in vivo model, we exposed male mice to HBCDD and then assessed alterations to the dopamine synapse 6 weeks later. These exposures elicited significant reductions in presynaptic dopaminergic proteins, including TH, COMT, MAO-B, DAT, VMAT2, and alpha-synuclein. In contrast, postsynaptic dopamine receptors were not impaired. These findings suggest that the mesohippocampal dopamine circuit is vulnerable to HBCDD and the dopamine terminal may be a selective target for alteration.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dopamine transporter; Hexabromocyclododecane; Hippocampus; Substantia nigra pars compacta; Tyrosine hydroxylase; Vesicular monoamine transporter 2

Mesh:

Substances:

Year:  2017        PMID: 28214749      PMCID: PMC5382642          DOI: 10.1016/j.etap.2017.02.003

Source DB:  PubMed          Journal:  Environ Toxicol Pharmacol        ISSN: 1382-6689            Impact factor:   4.860


  54 in total

1.  Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis.

Authors:  F J Lee; F Liu; Z B Pristupa; H B Niznik
Journal:  FASEB J       Date:  2001-04       Impact factor: 5.191

Review 2.  The dopaminergic mesencephalic projections to the hippocampal formation in the rat.

Authors:  A Gasbarri; A Sulli; M G Packard
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1997-01       Impact factor: 5.067

Review 3.  Biomonitoring-based risk assessment for hexabromocyclododecane (HBCD).

Authors:  Lesa L Aylward; Sean M Hays
Journal:  Int J Hyg Environ Health       Date:  2011-03-25       Impact factor: 5.840

Review 4.  Hexabromocyclododecanes (HBCDs) in the environment and humans: a review.

Authors:  Adrian Covaci; Andreas C Gerecke; Robin J Law; Stefan Voorspoels; Martin Kohler; Norbert V Heeb; Heather Leslie; Collin R Allchin; Jacob De Boer
Journal:  Environ Sci Technol       Date:  2006-06-15       Impact factor: 9.028

5.  Transient aberration of neuronal development in the hippocampal dentate gyrus after developmental exposure to brominated flame retardants in rats.

Authors:  Yukie Saegusa; Hitoshi Fujimoto; Gye-Hyeong Woo; Takumi Ohishi; Liyun Wang; Kunitoshi Mitsumori; Akiyoshi Nishikawa; Makoto Shibutani
Journal:  Arch Toxicol       Date:  2012-03-14       Impact factor: 5.153

6.  Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain.

Authors:  S J Boyson; P McGonigle; P B Molinoff
Journal:  J Neurosci       Date:  1986-11       Impact factor: 6.167

7.  Polychlorinated biphenyl-induced reduction of dopamine transporter expression as a precursor to Parkinson's disease-associated dopamine toxicity.

Authors:  W Michael Caudle; Jason R Richardson; Kristin C Delea; Thomas S Guillot; Minzheng Wang; Kurt D Pennell; Gary W Miller
Journal:  Toxicol Sci       Date:  2006-05-15       Impact factor: 4.849

Review 8.  The contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's disease.

Authors:  Matthew J Benskey; Ruth G Perez; Fredric P Manfredsson
Journal:  J Neurochem       Date:  2016-03-23       Impact factor: 5.372

Review 9.  Dopamine receptor mapping with PET imaging in Parkinson's disease.

Authors:  Flavia Niccolini; Paul Su; Marios Politis
Journal:  J Neurol       Date:  2014-03-15       Impact factor: 4.849

10.  Prenatal polybrominated diphenyl ether exposures and neurodevelopment in U.S. children through 5 years of age: the HOME study.

Authors:  Aimin Chen; Kimberly Yolton; Stephen A Rauch; Glenys M Webster; Richard Hornung; Andreas Sjödin; Kim N Dietrich; Bruce P Lanphear
Journal:  Environ Health Perspect       Date:  2014-05-28       Impact factor: 9.031

View more
  4 in total

1.  Update of the risk assessment of hexabromocyclododecanes (HBCDDs) in food.

Authors:  Dieter Schrenk; Margherita Bignami; Laurent Bodin; James Kevin Chipman; Jesús Del Mazo; Bettina Grasl-Kraupp; Christer Hogstrand; Laurentius Ron Hoogenboom; Jean-Charles Leblanc; Carlo Stefano Nebbia; Elsa Nielsen; Evangelia Ntzani; Annette Petersen; Salomon Sand; Tanja Schwerdtle; Heather Wallace; Diane Benford; Peter Fürst; Martin Rose; Sofia Ioannidou; Marina Nikolič; Luisa Ramos Bordajandi; Christiane Vleminckx
Journal:  EFSA J       Date:  2021-03-08

2.  A PBPK model describing the pharmacokinetics of γ-HBCD exposure in mice.

Authors:  Claude Emond; Michael J DeVito; Linda S Birnbaum
Journal:  Toxicol Appl Pharmacol       Date:  2021-08-11       Impact factor: 4.460

3.  Genetic or Toxicant-Induced Disruption of Vesicular Monoamine Storage and Global Metabolic Profiling in Caenorhabditis elegans.

Authors:  Joshua M Bradner; Vrinda Kalia; Fion K Lau; Monica Sharma; Meghan L Bucher; Michelle Johnson; Merry Chen; Douglas I Walker; Dean P Jones; Gary W Miller
Journal:  Toxicol Sci       Date:  2021-04-12       Impact factor: 4.849

4.  Sex-specific Disruption of the Prairie Vole Hypothalamus by Developmental Exposure to a Flame Retardant Mixture.

Authors:  Sagi Enicole A Gillera; William P Marinello; Kevin T Cao; Brian M Horman; Heather M Stapleton; Heather B Patisaul
Journal:  Endocrinology       Date:  2021-08-01       Impact factor: 5.051

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.